Tuan Tu Diep

CIK: 0002013809

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (10.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (52.6%)

Compensation grants

Other (G, F, J, C, D, …)7 (36.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SKYE

Skye Bioscience, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
7.1K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
75K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
75K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
150K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
150K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
9.2K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
9.2K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
22K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
22K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
125K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
8K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
8K shares-
SKYE
Skye Bioscience, Inc.
Mar 31, 2026
Award(A)
Stock Option (Right to Buy)
Direct
7.1K shares-
SKYE
Skye Bioscience, Inc.
Feb 6, 2026
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-
SKYE
Skye Bioscience, Inc.
Feb 24, 2025
Award(A)
Stock Option (Right to Buy)
Direct
150K shares-
SKYE
Skye Bioscience, Inc.
Nov 18, 2024
Sale(S)
Direct
19.5K shares at avg. $4.99$97K
SKYE
Skye Bioscience, Inc.
Nov 15, 2024
Sale(S)
Direct
85 shares at avg. $5.55$471.75
SKYE
Skye Bioscience, Inc.
Oct 28, 2024
Award(A)
Stock Option (Right to Buy)
Direct
125K shares-

		Type	Shares	Price		Ownership
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	7,080	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	75,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	75,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	150,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	150,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	9,194	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	9,194	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	22,021	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	22,021	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	125,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	8,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Disposition(D) Stock Option (Right to Buy)	8,000	-	-	Direct
Mar 31, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	7,080	-	-	Direct
Feb 6, 2026	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct
Feb 24, 2025	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	150,000	-	-	Direct
Nov 18, 2024	SKYE Skye Bioscience, Inc.	Sale(S)	19,489	$4.99	$97,250	Direct
Nov 15, 2024	SKYE Skye Bioscience, Inc.	Sale(S)	85	$5.55	$472	Direct
Oct 28, 2024	SKYE Skye Bioscience, Inc.	Award(A) Stock Option (Right to Buy)	125,000	-	-	Direct

1-19 of 19 transactions

About Diep Tuan Tu

Diep Tuan Tu (SEC CIK 0002013809) files insider reports with the SEC as Chief Operating Officer of Skye Bioscience, Inc. (SKYE).

Signal8 holds 6 ownership filings by Diep Tuan Tu (1 Form 3, 5 Form 4), filed between Oct 30, 2024 and Apr 2, 2026. Those filings report 19 transactions, from Oct 28, 2024 to Mar 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Diep Tuan Tu's filings is in SAN DIEGO, CA.

Recent filings by Diep Tuan Tu

Mar 31, 2026: Disposition to issuer transactions of SKYE derivative securities (2 lines, Form 4, code D).
Mar 31, 2026: Grants or awards of SKYE derivative securities (2 lines, Form 4, code A).
Mar 31, 2026: Disposition to issuer transaction of SKYE derivative securities (Form 4, code D).
Mar 31, 2026: Grant or award of SKYE derivative securities (Form 4, code A).
Mar 31, 2026: Disposition to issuer transaction of SKYE derivative securities (Form 4, code D).

Other insiders filing for Skye Bioscience, Inc. (SKYE)

Schwab Andrew J., Director
5AM Partners VII, LLC, 10% Owner
DHILLON PUNIT, Chief Executive Officer
Sharp John P, Chief Financial Officer
Smith Karen L., Director
Twitty Christopher, Chief Scientific Officer

How to read Form 4 transaction codes